Search results
Results from the WOW.Com Content Network
Oxitropium bromide (trade names Oxivent, Tersigan) is an anticholinergic used as a bronchodilator for the treatment of asthma and chronic obstructive pulmonary disease. [1] It was patented in 1966 and approved for medical use in 1983. [2]
It was made available for free at the National Library of Medicine's Virtual Asthma Exhibit. [10] In November 2002, the developers received a grant from the Centers for Disease Control and Prevention's (CDC) adolescent and school health program, allowing them to distribute the game to school nurses at more than 30,000 elementary, middle and ...
Currently, the U.S. Food and Drug Administration has not approved any oral immunotherapy agents for asthma. [21] In January 2020, the FDA approved Palforzia for mitigating "allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts." [22] [23] It is the first drug approved for peanut allergies. It will not ...
Clenbuterol is approved for use in some countries as a bronchodilator for asthma. [medical citation needed]Clenbuterol is a β 2 agonist with some structural and pharmacological similarities to epinephrine and salbutamol, but its effects are more potent and longer-lasting as a stimulant and thermogenic drug.
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
(The Center Square) – The University of Texas System may soon offer "tuition free education" to students whose families make less than $100,000 a year, a program some are calling “a socialist ...
Black children were 4.5 times more likely to be hospitalized for asthma than white children, and 7.6 times more likely to die from asthma, according to the federal Office of Minority Health ...
Tezepelumab, sold under the brand name Tezspire, is a human monoclonal antibody used for the treatment of asthma. [5] [7] [8] [9] Tezepelumab blocks thymic stromal lymphopoietin (TSLP), [5] an epithelial cytokine that has been suggested to be critical in the initiation and persistence of airway inflammation.